Human Coagulation Factor XIV/Protein C quantitates human Coagulation Factor XIV/Protein C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XIV/Protein C.
Accession number
Peptide d’activation ; protéine C anticoagulante ; APC ; IIA d’Autoprothrombine ; facteur de coagulation sanguin XIV ; EDQVRPLIDGK ; inactivateur des facteurs de coagulation Va, VIII ; PC ; protéine C prépro ; Proc ; Proc1 ; protéine C ; protéine C (inactivateur des facteurs de coagulation Va et VIIIa) ; protéine C prépropeptide ; protéine C, inactivateur des facteurs de coagulation Va et VIIIa ; THPH3 ; THPH4 ; protéine C de type I ; protéine C dépendante de la vitamine K ; protéine C dépendante de la vitamine K ; chaîne légère de la protéine C dépendante de la vitamine K ; protéine C dépendante de la vitamine K.
Dose range
0.82 to 20 ng/mL
Sensitivity of the dosage
0.82 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human Coagulation Factor XIV/Protein C quantitates human Coagulation Factor XIV/Protein C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XIV/Protein C.
Human Coagulation Factor XIV/Protein C quantitates human Coagulation Factor XIV/Protein C in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human Coagulation Factor XIV/Protein C.
Protein C is a vitamin K-dependent plasma glycoprotein that is cleaved by the thrombin-thrombomodulin complex in its activated form. The activated protein C contains a serine protease domain and functions in the degradation of activated forms of coagulation factors V and VIII. Protein C is a serum protease dependent on vitamin K produced in the liver and composed of 2 polypeptide chains. The 62 kDa proenzyme is activated by thrombin bound to an endothelial surface receptor and the active enzyme cleaves the factor Va and VIIIa and thus inhibits blood clotting. The molecular weight of the active enzyme is 55 kDa and normal concentrations in human plasma are about 1 to 3 ng/ml due to the very rapid turnover, the proenzyme concentration is about 3 μg/ml. Mutations in the protein C gene were associated with thrombophilia due to protein C deficiency, neonatal fulminan purpura and recurrent venous thrombosis.
Sensitivity
Sensitivity of dosage: 0.82 ng/mL.
Measurement range
Dose range: 0.82 to 20 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: Protein C.
Samples
Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17174393
Specifications
Accession number
Peptide d'activation; protein C anticoagulant; APC; IIA d-Autoprothrombin; blood clotting factor XIV; EDQVRPLIDGK ; inactivated coagulation factors Va, VIII; PC; prepro C protein; Proc; Proc1; protein C; protein C (inactivated coagulation factors Va and VII